OSUR
Price
$3.35
Change
-$0.14 (-4.01%)
Updated
Mar 10, 02:57 PM (EDT)
Capitalization
453.85M
58 days until earnings call
PACB
Price
$1.40
Change
+$0.06 (+4.51%)
Updated
Mar 10, 02:58 PM (EDT)
Capitalization
976.68M
59 days until earnings call
Ad is loading...

OSUR vs PACB

Header iconOSUR vs PACB Comparison
Open Charts OSUR vs PACBBanner chart's image
OraSure Technologies
Price$3.35
Change-$0.14 (-4.01%)
Volume$3.1K
Capitalization453.85M
Pacific Biosciences of California
Price$1.40
Change+$0.06 (+4.51%)
Volume$15.44K
Capitalization976.68M
OSUR vs PACB Comparison Chart
Loading...
OSUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OSUR vs. PACB commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSUR is a StrongBuy and PACB is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (OSUR: $3.37 vs. PACB: $1.35)
Brand notoriety: OSUR and PACB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: OSUR: 121% vs. PACB: 88%
Market capitalization -- OSUR: $453.85M vs. PACB: $976.68M
OSUR [@Medical Specialties] is valued at $453.85M. PACB’s [@Medical Specialties] market capitalization is $976.68M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OSUR’s FA Score shows that 1 FA rating(s) are green whilePACB’s FA Score has 0 green FA rating(s).

  • OSUR’s FA Score: 1 green, 4 red.
  • PACB’s FA Score: 0 green, 5 red.
According to our system of comparison, OSUR is a better buy in the long-term than PACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OSUR’s TA Score shows that 4 TA indicator(s) are bullish while PACB’s TA Score has 2 bullish TA indicator(s).

  • OSUR’s TA Score: 4 bullish, 6 bearish.
  • PACB’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, OSUR is a better buy in the short-term than PACB.

Price Growth

OSUR (@Medical Specialties) experienced а -15.75% price change this week, while PACB (@Medical Specialties) price change was -13.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.19%. For the same industry, the average monthly price growth was -7.49%, and the average quarterly price growth was -4.16%.

Reported Earning Dates

OSUR is expected to report earnings on May 07, 2025.

PACB is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Medical Specialties (-2.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PACB($977M) has a higher market cap than OSUR($454M). OSUR YTD gains are higher at: -6.648 vs. PACB (-26.230). OSUR has higher annual earnings (EBITDA): 64.4M vs. PACB (-277.28M). PACB has more cash in the bank: 631M vs. OSUR (290M). OSUR has less debt than PACB: OSUR (13.5M) vs PACB (934M). OSUR has higher revenues than PACB: OSUR (405M) vs PACB (201M).
OSURPACBOSUR / PACB
Capitalization454M977M46%
EBITDA64.4M-277.28M-23%
Gain YTD-6.648-26.23025%
P/E Ratio8.44N/A-
Revenue405M201M201%
Total Cash290M631M46%
Total Debt13.5M934M1%
FUNDAMENTALS RATINGS
OSUR vs PACB: Fundamental Ratings
OSUR
PACB
OUTLOOK RATING
1..100
671
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8186
P/E GROWTH RATING
1..100
576
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OSUR's Valuation (68) in the Medical Specialties industry is in the same range as PACB (100) in the Biotechnology industry. This means that OSUR’s stock grew similarly to PACB’s over the last 12 months.

OSUR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as PACB (100) in the Biotechnology industry. This means that OSUR’s stock grew similarly to PACB’s over the last 12 months.

OSUR's SMR Rating (100) in the Medical Specialties industry is in the same range as PACB (100) in the Biotechnology industry. This means that OSUR’s stock grew similarly to PACB’s over the last 12 months.

OSUR's Price Growth Rating (81) in the Medical Specialties industry is in the same range as PACB (86) in the Biotechnology industry. This means that OSUR’s stock grew similarly to PACB’s over the last 12 months.

OSUR's P/E Growth Rating (5) in the Medical Specialties industry is significantly better than the same rating for PACB (76) in the Biotechnology industry. This means that OSUR’s stock grew significantly faster than PACB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OSURPACB
RSI
ODDS (%)
Bullish Trend 7 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
72%
Bullish Trend 7 days ago
89%
Momentum
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
88%
MACD
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 7 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 21 days ago
85%
Declines
ODDS (%)
Bearish Trend 18 days ago
81%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
83%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
81%
View a ticker or compare two or three
Ad is loading...
OSUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

OSUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, OSUR has been loosely correlated with LMAT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OSUR jumps, then LMAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSUR
1D Price
Change %
OSUR100%
-5.60%
LMAT - OSUR
37%
Loosely correlated
-1.83%
CRL - OSUR
34%
Loosely correlated
+0.50%
IQV - OSUR
32%
Poorly correlated
-0.69%
QDEL - OSUR
31%
Poorly correlated
-0.20%
BFLY - OSUR
29%
Poorly correlated
-0.33%
More

PACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PACB has been loosely correlated with AZTA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PACB jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PACB
1D Price
Change %
PACB100%
+2.66%
AZTA - PACB
44%
Loosely correlated
-0.10%
TWST - PACB
40%
Loosely correlated
+6.93%
VCYT - PACB
40%
Loosely correlated
+1.64%
HBIO - PACB
39%
Loosely correlated
-4.38%
SGHT - PACB
38%
Loosely correlated
-1.59%
More